FDA Advisers Endorse Return of Multiple Sclerosis Drug (HealthDay via
FDA Advisers Endorse Return of Multiple Sclerosis Drug (HealthDay via Yahoo! News)
WEDNESDAY, March 8 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel voted unanimously Wednesday to allow the promising but controversial multiple sclerosis drug Tysabri back on the market.